Polysialic Acid-Polycaprolactone Micelles for Drug Delivery

Rebecca Bader (Inventor)

Research output: Patent


PSA-PCL micelles were developed as carrier systems for pharmaceutical drugs. As an example, cyclosporine A (CyA) was encapsulated in the micelles and physical characterization, including size and zeta potential, demonstrated that the micelles possess favorable properties for drug delivery. In vitro studies verified that rheumatoid arthritis synovial fibroblasts are able to internalize the CyA-loaded micelles. CyA was released from the PSA-PCL micelle upon uptake and subsequently, partitioned into the phospholipid membrane. The PSA-PCL micelles also demonstrated improved therapeutic efficacy in drug delivery when used to deliver statins and disease modifying anti-rheumatic drugs (DMARDs).
Original languageEnglish (US)
Patent number10,022,324
StatePublished - Jul 17 2018


Dive into the research topics of 'Polysialic Acid-Polycaprolactone Micelles for Drug Delivery'. Together they form a unique fingerprint.

Cite this